Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 637 entries
Sorted by: Best Match Show Resources per page
French physicians' knowledge about hereditary breast/ovarian cancer: the need for continuing vocational training in genetics.

Community genetics

Julian-Reynier C, Eisinger F, Moatti JP, Sobol H.
PMID: 14960837
Community Genet. 1999;2(4):165-72. doi: 10.1159/000016207.

OBJECTIVES: The aim of this study was to determine what medical specialists knew about recent findings in the genetics of breast/ovarian cancer, according to their speciality and the methods they used to keep themselves up to date.METHODS: A national...

Cite
Julian-Reynier C, Eisinger F, Moatti JP, et al. French physicians' knowledge about hereditary breast/ovarian cancer: the need for continuing vocational training in genetics. Community Genet. 1999;2(4):165-72doi: 10.1159/000016207.
Julian-Reynier, C., Eisinger, F., Moatti, J. P., & Sobol, H. (1999). French physicians' knowledge about hereditary breast/ovarian cancer: the need for continuing vocational training in genetics. Community genetics, 2(4), 165-72. https://doi.org/10.1159/000016207
Julian-Reynier, C, et al. "French physicians' knowledge about hereditary breast/ovarian cancer: the need for continuing vocational training in genetics." Community genetics vol. 2,4 (1999): 165-72. doi: https://doi.org/10.1159/000016207
Julian-Reynier C, Eisinger F, Moatti JP, Sobol H. French physicians' knowledge about hereditary breast/ovarian cancer: the need for continuing vocational training in genetics. Community Genet. 1999;2(4):165-72. doi: 10.1159/000016207. PMID: 14960837.
Copy Download .nbib Format: NLM
METAMET--two leveled medical IS design approach.

Medinfo. MEDINFO

Kokol P.
PMID: 8591229
Medinfo. 1995;8:460.

New opportunities posed by the huge advancement of information technology, the self-image of medical users, and the so-called patient centered design results in the slogan: It is not enough to do more efficiently what we are doing now, but...

Cite
Kokol P. METAMET--two leveled medical IS design approach. Medinfo. 1995;8:460
Kokol, P. (1995). METAMET--two leveled medical IS design approach. Medinfo. MEDINFO, 8460.
Kokol, P. "METAMET--two leveled medical IS design approach." Medinfo. MEDINFO vol. 8 (1995): 460.
Kokol P. METAMET--two leveled medical IS design approach. Medinfo. 1995;8:460. PMID: 8591229.
Copy Download .nbib Format: NLM
Using multiagent system for gene expression classification.

Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference

Stiglic G, Kokol P.
PMID: 17270897
Conf Proc IEEE Eng Med Biol Soc. 2004;2004:2952-5. doi: 10.1109/IEMBS.2004.1403838.

Recent advances in microarray technology offer the ability to measure expression levels of thousands of genes simultaneously. Analysis of such data can help us identifying different clinical outcomes using only expressions of a few predictive genes. This paper presents...

Cite
Stiglic G, Kokol P. Using multiagent system for gene expression classification. Conf Proc IEEE Eng Med Biol Soc. 2004;2004:2952-5doi: 10.1109/IEMBS.2004.1403838.
Stiglic, G., & Kokol, P. (2004). Using multiagent system for gene expression classification. Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference, 20042952-5. https://doi.org/10.1109/IEMBS.2004.1403838
Stiglic, Gregor, and Kokol, Peter. "Using multiagent system for gene expression classification." Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference vol. 2004 (2004): 2952-5. doi: https://doi.org/10.1109/IEMBS.2004.1403838
Stiglic G, Kokol P. Using multiagent system for gene expression classification. Conf Proc IEEE Eng Med Biol Soc. 2004;2004:2952-5. doi: 10.1109/IEMBS.2004.1403838. PMID: 17270897.
Copy Download .nbib Format: NLM
Evidence-based medicine for rare diseases: implications for data interpretation and clinical trial design.

Cancer control : journal of the Moffitt Cancer Center

Behera M, Kumar A, Soares HP, Sokol L, Djulbegovic B.
PMID: 17387301
Cancer Control. 2007 Apr;14(2):160-6. doi: 10.1177/107327480701400209.

BACKGROUND: The randomized, controlled trial (RCT) is the "gold standard" for establishing the effect of any intervention. This approach, however, is often not feasible with rare diseases such as cutaneous T-cell lymphoma.METHODS: We review the principles of evidence-based medicine...

Cite
Behera M, Kumar A, Soares HP, et al. Evidence-based medicine for rare diseases: implications for data interpretation and clinical trial design. Cancer Control. 2007;14(2):160-6doi: 10.1177/107327480701400209.
Behera, M., Kumar, A., Soares, H. P., Sokol, L., & Djulbegovic, B. (2007). Evidence-based medicine for rare diseases: implications for data interpretation and clinical trial design. Cancer control : journal of the Moffitt Cancer Center, 14(2), 160-6. https://doi.org/10.1177/107327480701400209
Behera, Madhusmita, et al. "Evidence-based medicine for rare diseases: implications for data interpretation and clinical trial design." Cancer control : journal of the Moffitt Cancer Center vol. 14,2 (2007): 160-6. doi: https://doi.org/10.1177/107327480701400209
Behera M, Kumar A, Soares HP, Sokol L, Djulbegovic B. Evidence-based medicine for rare diseases: implications for data interpretation and clinical trial design. Cancer Control. 2007 Apr;14(2):160-6. doi: 10.1177/107327480701400209. PMID: 17387301.
Copy Download .nbib Format: NLM
Optical resolution of 1-(1-naphthyl)ethylamine by its dicarboxylic acid derivatives: Structural features of the oxalic acid derivative diastereomeric salt pair.

Chirality

Bereczki L, Bombicz P, Bálint J, Egri G, Schindler J, Pokol G, Fogassy E, Marthi K.
PMID: 18571802
Chirality. 2009 Mar;21(3):331-8. doi: 10.1002/chir.20535.

Optical resolution methods were established for racemic 1-(1-naphthyl) ethylamine. The resolving agents were synthesized by N-derivatizing (R)-1-(1-naphthyl) ethylamine with dicarboxylic acids. Oxalic, malonic, and succinic acid derivatives were found to be suitable resolving agents. These resolutions are parallel to...

Cite
Bereczki L, Bombicz P, Bálint J, et al. Optical resolution of 1-(1-naphthyl)ethylamine by its dicarboxylic acid derivatives: Structural features of the oxalic acid derivative diastereomeric salt pair. Chirality. 2009;21(3):331-8doi: 10.1002/chir.20535.
Bereczki, L., Bombicz, P., Bálint, J., Egri, G., Schindler, J., Pokol, G., Fogassy, E., & Marthi, K. (2009). Optical resolution of 1-(1-naphthyl)ethylamine by its dicarboxylic acid derivatives: Structural features of the oxalic acid derivative diastereomeric salt pair. Chirality, 21(3), 331-8. https://doi.org/10.1002/chir.20535
Bereczki, Laura, et al. "Optical resolution of 1-(1-naphthyl)ethylamine by its dicarboxylic acid derivatives: Structural features of the oxalic acid derivative diastereomeric salt pair." Chirality vol. 21,3 (2009): 331-8. doi: https://doi.org/10.1002/chir.20535
Bereczki L, Bombicz P, Bálint J, Egri G, Schindler J, Pokol G, Fogassy E, Marthi K. Optical resolution of 1-(1-naphthyl)ethylamine by its dicarboxylic acid derivatives: Structural features of the oxalic acid derivative diastereomeric salt pair. Chirality. 2009 Mar;21(3):331-8. doi: 10.1002/chir.20535. PMID: 18571802.
Copy Download .nbib Format: NLM
West nile epidemic in louisiana in 2002.

The Ochsner journal

Balsamo G, Michaels S, Sokol T, Lees K, Mehta M, Straif-Bourgeois S, Hall S, Krishna N, Talati G, Ratard R.
PMID: 21765763
Ochsner J. 2003;5(3):13-5.

In 2002, 329 cases of West Nile illness were reported in Louisiana, including 204 cases of West Nile meningoencephalitis and 125 cases of West Nile fever. Clinical presentation of meningoencephalitis or of West Nile fever was confirmed serologically. There...

Cite
Balsamo G, Michaels S, Sokol T, et al. West nile epidemic in louisiana in 2002. Ochsner J. 2003;5(3):13-5
Balsamo, G., Michaels, S., Sokol, T., Lees, K., Mehta, M., Straif-Bourgeois, S., Hall, S., Krishna, N., Talati, G., & Ratard, R. (2003). West nile epidemic in louisiana in 2002. The Ochsner journal, 5(3), 13-5.
Balsamo, Gary, et al. "West nile epidemic in louisiana in 2002." The Ochsner journal vol. 5,3 (2003): 13-5.
Balsamo G, Michaels S, Sokol T, Lees K, Mehta M, Straif-Bourgeois S, Hall S, Krishna N, Talati G, Ratard R. West nile epidemic in louisiana in 2002. Ochsner J. 2003;5(3):13-5. PMID: 21765763; PMCID: PMC3111823.
Copy Download .nbib Format: NLM
Body mass index and disease activity at treatment initiation: potential new predictors of response to azathioprine therapy in IBD.

Inflammatory bowel diseases

Sokol H, Beaugerie L.
PMID: 19760776
Inflamm Bowel Dis. 2010 Apr;16(4):714-5. doi: 10.1002/ibd.21102.

No abstract available.

Cite
Sokol H, Beaugerie L. Body mass index and disease activity at treatment initiation: potential new predictors of response to azathioprine therapy in IBD. Inflamm Bowel Dis. 2010;16(4):714-5doi: 10.1002/ibd.21102.
Sokol, H., & Beaugerie, L. (2010). Body mass index and disease activity at treatment initiation: potential new predictors of response to azathioprine therapy in IBD. Inflammatory bowel diseases, 16(4), 714-5. https://doi.org/10.1002/ibd.21102
Sokol, Harry, and Beaugerie, Laurent. "Body mass index and disease activity at treatment initiation: potential new predictors of response to azathioprine therapy in IBD." Inflammatory bowel diseases vol. 16,4 (2010): 714-5. doi: https://doi.org/10.1002/ibd.21102
Sokol H, Beaugerie L. Body mass index and disease activity at treatment initiation: potential new predictors of response to azathioprine therapy in IBD. Inflamm Bowel Dis. 2010 Apr;16(4):714-5. doi: 10.1002/ibd.21102. PMID: 19760776.
Copy Download .nbib Format: NLM
Appendicitis, not appendectomy, is protective against ulcerative colitis, both in the general population and first-degree relatives of patients with IBD.

Inflammatory bowel diseases

Beaugerie L, Sokol H.
PMID: 19685454
Inflamm Bowel Dis. 2010 Feb;16(2):356-7. doi: 10.1002/ibd.21064.

No abstract available.

Cite
Beaugerie L, Sokol H. Appendicitis, not appendectomy, is protective against ulcerative colitis, both in the general population and first-degree relatives of patients with IBD. Inflamm Bowel Dis. 2010;16(2):356-7doi: 10.1002/ibd.21064.
Beaugerie, L., & Sokol, H. (2010). Appendicitis, not appendectomy, is protective against ulcerative colitis, both in the general population and first-degree relatives of patients with IBD. Inflammatory bowel diseases, 16(2), 356-7. https://doi.org/10.1002/ibd.21064
Beaugerie, Laurent, and Sokol, Harry. "Appendicitis, not appendectomy, is protective against ulcerative colitis, both in the general population and first-degree relatives of patients with IBD." Inflammatory bowel diseases vol. 16,2 (2010): 356-7. doi: https://doi.org/10.1002/ibd.21064
Beaugerie L, Sokol H. Appendicitis, not appendectomy, is protective against ulcerative colitis, both in the general population and first-degree relatives of patients with IBD. Inflamm Bowel Dis. 2010 Feb;16(2):356-7. doi: 10.1002/ibd.21064. PMID: 19685454.
Copy Download .nbib Format: NLM
Radiotherapy in Malignant Myoepithelioma of the Soft Palate - Case Report.

Case reports in oncology

Soumarová R, Lovasová Z, Vaňková M, Sokol L.
PMID: 20740173
Case Rep Oncol. 2009 Jul 17;2(2):116-120. doi: 10.1159/000228546.

Myoepithelioma is a very rare neoplasm that accounts only for about 1% of all salivary gland tumours. As the lesion is so rare, there are no specific recommendations or guidelines for its treatment. In the literature, there have been...

Cite
Soumarová R, Lovasová Z, Vaňková M, et al. Radiotherapy in Malignant Myoepithelioma of the Soft Palate - Case Report. Case Rep Oncol. 2009;2(2):116-120doi: 10.1159/000228546.
Soumarová, R., Lovasová, Z., Vaňková, M., & Sokol, L. (2009). Radiotherapy in Malignant Myoepithelioma of the Soft Palate - Case Report. Case reports in oncology, 2(2), 116-120. https://doi.org/10.1159/000228546
Soumarová, Renata, et al. "Radiotherapy in Malignant Myoepithelioma of the Soft Palate - Case Report." Case reports in oncology vol. 2,2 (2009): 116-120. doi: https://doi.org/10.1159/000228546
Soumarová R, Lovasová Z, Vaňková M, Sokol L. Radiotherapy in Malignant Myoepithelioma of the Soft Palate - Case Report. Case Rep Oncol. 2009 Jul 17;2(2):116-120. doi: 10.1159/000228546. PMID: 20740173; PMCID: PMC2918858.
Copy Download .nbib Format: NLM
9-Meth-oxy-6a,11a-dimethyl-6a,11a-dihydro-6H-1-benzofuro[3,2-c]chromen-3-ol from Dalbergia oliveri.

Acta crystallographica. Section E, Structure reports online

Deesamer S, Chavasiri W, Chaichit N, Muangsin N, Kokpol U.
PMID: 21577851
Acta Crystallogr Sect E Struct Rep Online. 2009 Sep 09;65:o2387. doi: 10.1107/S1600536809034485.

The title compound, commonly known as (+)-(6aS,11aS)-medicarpin, C(16)H(14)O(4), was isolated from Dalbergia oliveri and displays a rigid mol-ecule consisting of four fused rings. The benzofuran system is inclined at an angle of 76.49 (2)° with respect to the chroman...

Cite
Deesamer S, Chavasiri W, Chaichit N, et al. 9-Meth-oxy-6a,11a-dimethyl-6a,11a-dihydro-6H-1-benzofuro[3,2-c]chromen-3-ol from Dalbergia oliveri. Acta Crystallogr Sect E Struct Rep Online. 2009;65:o2387doi: 10.1107/S1600536809034485.
Deesamer, S., Chavasiri, W., Chaichit, N., Muangsin, N., & Kokpol, U. (2009). 9-Meth-oxy-6a,11a-dimethyl-6a,11a-dihydro-6H-1-benzofuro[3,2-c]chromen-3-ol from Dalbergia oliveri. Acta crystallographica. Section E, Structure reports online, 65o2387. https://doi.org/10.1107/S1600536809034485
Deesamer, Sujittra, et al. "9-Meth-oxy-6a,11a-dimethyl-6a,11a-dihydro-6H-1-benzofuro[3,2-c]chromen-3-ol from Dalbergia oliveri." Acta crystallographica. Section E, Structure reports online vol. 65 (2009): o2387. doi: https://doi.org/10.1107/S1600536809034485
Deesamer S, Chavasiri W, Chaichit N, Muangsin N, Kokpol U. 9-Meth-oxy-6a,11a-dimethyl-6a,11a-dihydro-6H-1-benzofuro[3,2-c]chromen-3-ol from Dalbergia oliveri. Acta Crystallogr Sect E Struct Rep Online. 2009 Sep 09;65:o2387. doi: 10.1107/S1600536809034485. PMID: 21577851; PMCID: PMC2970239.
Copy Download .nbib Format: NLM
The prevalence of human papillomavirus and its impact on cervical dysplasia in Northern Canada.

Infectious agents and cancer

Jiang Y, Brassard P, Severini A, Mao Y, Li YA, Laroche J, Chatwood S, Corriveau A, Kandola K, Hanley B, Sobol I, Ar-Rushdi M, Johnson G, Lo J, Ratnam S, Wong T, Demers A, Jayaraman G, Totten S, Morrison H.
PMID: 23816397
Infect Agent Cancer. 2013 Jul 01;8(1):25. doi: 10.1186/1750-9378-8-25.

INTRODUCTION: Certain types of the Human Papillomavirus (HPV) are sexually transmitted and highly associated with development of cervical dysplasia and cervical cancer but the distribution of HPV infection in the North, particularly amongst First Nations, Metis, and Inuit peoples,...

Cite
Jiang Y, Brassard P, Severini A, et al. The prevalence of human papillomavirus and its impact on cervical dysplasia in Northern Canada. Infect Agent Cancer. 2013;8(1):25doi: 10.1186/1750-9378-8-25.
Jiang, Y., Brassard, P., Severini, A., Mao, Y., Li, Y. A., Laroche, J., Chatwood, S., Corriveau, A., Kandola, K., Hanley, B., Sobol, I., Ar-Rushdi, M., Johnson, G., Lo, J., Ratnam, S., Wong, T., Demers, A., Jayaraman, G., Totten, S., & Morrison, H. (2013). The prevalence of human papillomavirus and its impact on cervical dysplasia in Northern Canada. Infectious agents and cancer, 8(1), 25. https://doi.org/10.1186/1750-9378-8-25
Jiang, Ying, et al. "The prevalence of human papillomavirus and its impact on cervical dysplasia in Northern Canada." Infectious agents and cancer vol. 8,1 (2013): 25. doi: https://doi.org/10.1186/1750-9378-8-25
Jiang Y, Brassard P, Severini A, Mao Y, Li YA, Laroche J, Chatwood S, Corriveau A, Kandola K, Hanley B, Sobol I, Ar-Rushdi M, Johnson G, Lo J, Ratnam S, Wong T, Demers A, Jayaraman G, Totten S, Morrison H. The prevalence of human papillomavirus and its impact on cervical dysplasia in Northern Canada. Infect Agent Cancer. 2013 Jul 01;8(1):25. doi: 10.1186/1750-9378-8-25. PMID: 23816397; PMCID: PMC3728116.
Copy Download .nbib Format: NLM
Sublocalization of smallest common regions of deletion on chromosome 17q12-q23 in sporadic primary breast-tumors.

Oncology reports

Champeme M, Mazoyer S, Stoppalyonnet D, Bieche I, Ithier G, Sobol H, Nogues C, Lidereau R.
PMID: 21597825
Oncol Rep. 1995 Sep;2(5):825-31. doi: 10.3892/or.2.5.825.

Frequent loss of heterozygosity (LOH) on the long arm of chromosome 17 has been described in breast tumor DNAs by a number of groups, and recent fine genetic mapping and cloning of an inherited breast-ovarian cancer susceptibility locus (BRCA1)...

Cite
Champeme M, Mazoyer S, Stoppalyonnet D, et al. Sublocalization of smallest common regions of deletion on chromosome 17q12-q23 in sporadic primary breast-tumors. Oncol Rep. 1995;2(5):825-31doi: 10.3892/or.2.5.825.
Champeme, M., Mazoyer, S., Stoppalyonnet, D., Bieche, I., Ithier, G., Sobol, H., Nogues, C., & Lidereau, R. (1995). Sublocalization of smallest common regions of deletion on chromosome 17q12-q23 in sporadic primary breast-tumors. Oncology reports, 2(5), 825-31. https://doi.org/10.3892/or.2.5.825
Champeme, M, et al. "Sublocalization of smallest common regions of deletion on chromosome 17q12-q23 in sporadic primary breast-tumors." Oncology reports vol. 2,5 (1995): 825-31. doi: https://doi.org/10.3892/or.2.5.825
Champeme M, Mazoyer S, Stoppalyonnet D, Bieche I, Ithier G, Sobol H, Nogues C, Lidereau R. Sublocalization of smallest common regions of deletion on chromosome 17q12-q23 in sporadic primary breast-tumors. Oncol Rep. 1995 Sep;2(5):825-31. doi: 10.3892/or.2.5.825. PMID: 21597825.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 637 entries